Belmont, CA · Founded 2021 · Privately Held (backing)
Operator of a drug development platform intended to develop novel antibody-drug conjugates. Solve Therapeutics is based in Belmont, CA and was founded in 2021. It was valued at $439 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $385 million across 3 recorded rounds; the latest was a $48.2 million early-stage round in Nov 2025.
PMV mark · valuation
$439.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$384.5M
Last round
Early Stage VC
Nov 2025
Cap table — not yet on record
Solve Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Solve Therapeutics with a free account
·The complete investor list: 16 names
·Watch Solve Therapeutics: the Monday email on marks, rounds and moves
Where does Solve Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Solve Therapeutics's 3 recorded funding rounds.
